Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 6Breast Neoplasms 5Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm Metastasis 2Lymphoma 2Lung Neoplasms 2Cardiovascular Diseases 2Bone Diseases, Metabolic 2Stomach Neoplasms 1Psychological Well-Being 1Pain 1Neoplasms 1Myocardial Ischemia 1Multiple Myeloma 1Motor Activity 1Melanoma, Cutaneous Malignant 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Heart Diseases 1Fractures, Bone 1Esophageal Neoplasms 1Disease Progression 1Coronary Disease 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bone Diseases 1

Interventions

Zoledronic Acid 4Denosumab 4Toremifene 2Vitamin D 1Cholecalciferol 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Fractures, Bone × Vitamin D × Clear all
NCT01646437 2021-09-16

TIPS-3

Population Health Research Institute

Phase 3 Completed
7,793 enrolled

Cardiovascular Diseases, Neoplasms, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡